Literature DB >> 24604126

Recent insights into hepatitis B virus-host interactions.

Sayeh Ezzikouri1, Makoto Ozawa, Michinori Kohara, Naima Elmdaghri, Soumaya Benjelloun, Kyoko Tsukiyama-Kohara.   

Abstract

Hepatitis B virus (HBV) poses a threat to global public health mainly because of complications of HBV-related chronic liver disease. HBV exhibits a narrow host range, replicating primarily in hepatocytes by a still poorly understood mechanism. For the generation of progeny virions, HBV depends on interactions with specific host factors through its life cycle. Revealing and characterizing these interactions are keys to identifying novel antiviral targets, and to developing specific treatment strategies for HBV patients. In this review, recent insights into the HBV-host interactions, especially on virus entry, intracellular trafficking, genome transcription and replication, budding and release, and even cellular restriction factors were reviewed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HBV; cccDNA; host factors; new target; receptors; replication

Mesh:

Year:  2014        PMID: 24604126     DOI: 10.1002/jmv.23916

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Expression of S100 proteins is associated with HBV intrauterine transmission.

Authors:  Peng Zhao; Jie Wen; Linyan Qian; Xiaojun Zhu; Hong Wang; Xiaoxia Bai
Journal:  Arch Gynecol Obstet       Date:  2020-08-27       Impact factor: 2.344

2.  A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liver.

Authors:  Jun Hu; Yaxing Xu; Changfei Li; Junli Hao; Shanxin Peng; Xiaoyu Chu; Dake Zhang; Dongping Xu; Songdong Meng
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

3.  ZEB2 inhibits HBV transcription and replication by targeting its core promoter.

Authors:  Qiao He; Wanyu Li; Jihua Ren; Yecai Huang; Ying Huang; Qin Hu; Juan Chen; Weixian Chen
Journal:  Oncotarget       Date:  2016-03-29

4.  Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.

Authors:  Satadru Jha; Federico Ramadori; Santina Quarta; Alessandra Biasiolo; Enrica Fabris; Paola Baldan; Gaetano Guarino; Mariagrazia Ruvoletto; Gianmarco Villano; Cristian Turato; Angelo Gatta; Fabrizio Mancin; Patrizia Pontisso; Paolo Scrimin
Journal:  Bioconjug Chem       Date:  2016-11-02       Impact factor: 4.774

Review 5.  Advances in the genome-wide association study of chronic hepatitis B susceptibility in Asian population.

Authors:  Bing Qiu; Wei Jiang; Mojtaba Olyaee; Kenji Shimura; Akihiro Miyakawa; Huijing Hu; Yongcui Zhu; Lixin Tang
Journal:  Eur J Med Res       Date:  2017-12-28       Impact factor: 2.175

6.  SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation.

Authors:  Hua Yang; Jiayin Mo; Qi Xiang; Peiyi Zhao; Yunting Song; Ge Yang; Kailang Wu; Yingle Liu; Weiyong Liu; Jianguo Wu
Journal:  Viruses       Date:  2020-02-29       Impact factor: 5.048

7.  The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression.

Authors:  Muhammad Sajid; Hafiz Ullah; Kun Yan; Miao He; Jiangpeng Feng; Muhammad Adnan Shereen; Ruidong Hao; Qiaohong Li; Deyin Guo; Yu Chen; Li Zhou
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 8.  Current landscape and future prospects of antiviral drugs derived from microbial products.

Authors:  Naoki Takizawa; Manabu Yamasaki
Journal:  J Antibiot (Tokyo)       Date:  2017-10-11       Impact factor: 2.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.